PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 151 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,000 | -12.5% | 3,772 | +22.4% | 0.00% | – |
| Q4 2019 | $16,000 | 0.0% | 3,081 | -3.4% | 0.00% | – |
| Q3 2019 | $16,000 | -15.8% | 3,191 | +5.3% | 0.00% | – |
| Q2 2019 | $19,000 | +72.7% | 3,031 | +23.7% | 0.00% | – |
| Q1 2019 | $11,000 | +22.2% | 2,450 | +15.0% | 0.00% | – |
| Q4 2018 | $9,000 | -10.0% | 2,130 | +33.5% | 0.00% | – |
| Q3 2018 | $10,000 | +400.0% | 1,595 | +488.6% | 0.00% | – |
| Q2 2018 | $2,000 | – | 271 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
| Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
| Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
| Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
| BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
| PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
| Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |